Crescentis Capital Board Meeting Date
Crescentis Capital Ltd intimated BSE of a board meeting on 12 November 2026 to approve Q2 and half-year unaudited results. It also notes the trading window stays closed until 48 hours after results.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Crescentis Capital Ltd intimated BSE of a board meeting on 12 November 2026 to approve Q2 and half-year unaudited results. It also notes the trading window stays closed until 48 hours after results.
Crescentis Capital's board approved the Letter of Offer for a rights issue of 1,02,08,129 shares at Rs.78 each. The issue aggregates to Rs.7,962.34 lakhs, or about Rs.79.62 Crore, assuming full subscription.
Crescentis Capital approved Rights Issue terms: 1,02,08,129 shares at ₹78, raising ₹79.62 Crore. Record date November 4; issue closes November 27, 2026.
Crescentis Capital will hold a Fund-Raising Committee meeting on 29 October 2026 to approve the terms of a proposed rights issue of up to Rs 80 crore. The filing is a prior intimation of that committee meeting.
Crescentis Capital Limited submitted the Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, as per SEBI regulations.
Crescentis Capital Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Crescentis Capital Limited granted 5,00,000 stock options to its Managing Director, Mr. Subba Rao Veeravenkata Meka, under the company's 2025 ESOS scheme.
Crescentis Capital Limited's board has approved a rights issue of equity shares for up to Rs 80 Crore. The board also approved the Draft Letter of Offer.
Crescentis Capital will hold a board meeting on September 29, 2026, to discuss progress on its proposed rights issue of equity shares.
Crescentis Capital Limited conducted its 33rd Annual General Meeting on August 26, 2026. The meeting transacted key business, including director reappointments and ESOP plan approvals.
Crescentis Capital Ltd reported revenue from operations of ₹10.9 Cr (+118.0% YoY) and net profit of ₹7.8 Cr (+129.4% YoY) for Q1 FY27.